Loading stock data…
Loading stock data…
US$0.00
Get one email when PTPI crosses your level. Checked every 15 minutes during market hours.
▲ +0.00 (2.27%)up today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
37.7
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.00
Bearish momentumMACD below its signal line (-0.00).
50-day average
0.01
Price belowShort-term trend reference.
200-day average
0.01
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Drug Manufacturers - Specialty & Generic
Petros Pharmaceuticals Inc. is a company specializing in the development and commercialization of pharmaceuticals in the field of men's health. Its primary focus is on treatments related to male sexual health, offering innovative solutions designed to enhance quality of life. Notable for its flagship product, Stendra, a prescription medication used to treat erectile dysfunction, Petros Pharmaceuticals aims to deliver impactful therapies that address significant medical needs. Operating within th…
petrospharma.com2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2025-02-01)
2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2025-01-01)
2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2024-12-01)
2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2024-11-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-01-15 | 2.98 | 3.14 | ✓ Beat |
| 2024-11-13 | -7.25 | -13.25 | ✗ Miss |
| 2024-08-14 | -19.25 | -9.25 | ✓ Beat |
| 2024-05-15 | -36 | -42.25 | ✗ Miss |
| 2024-04-01 | -27.75 | -54.25 | ✗ Miss |
| 2023-05-14 | — | -6.6 | — |
| 2023-03-30 | — | -2.03 | — |
| 2022-11-14 | — | -6.7 | — |
Companies in the same industry, via Finnhub